Narcotic Analgesics — Competitive Intelligence Brief

Narcotic Analgesics (Narcotic Analgesics) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Narcotic analgesic. Area: Pain management.

phase 3 Narcotic analgesic Opioid receptors (mu, delta, kappa) Pain management Small molecule

Target snapshot

Narcotic Analgesics (Narcotic Analgesics) — Ain Shams University. Narcotic analgesics work by binding to opioid receptors in the brain, spinal cord, and other areas, altering the perception of and response to pain.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Narcotic Analgesics TARGET	Narcotic Analgesics	Ain Shams University	phase 3	Narcotic analgesic	Opioid receptors (mu, delta, kappa)
Acetaminophen, Analgesics, Non-Narcotic	Acetaminophen, Analgesics, Non-Narcotic	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	phase 3	Non-narcotic analgesic and antipyretic	Cyclooxygenase (COX), primarily central nervous system isoforms

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Narcotic analgesic class)

1. Ain Shams University · 1 drug in this class